Clinical Study

A Phase 1, Multiple-Dose, Open-Label Study To Evaluate The Safety,Tolerability, And Pharmacokinetics Of Olz/Sam In Pediatric Subjects (10-12 Years Old) With Bipolar I Disorder

Posted Date: Jun 15, 2021

  • Investigator: Melissa Delbello
  • Specialties: Bipolar Disorder, Psychiatry/Psychology
  • Type of Study: Drug

A study to evaluate the safety, tolerability, and pharmacokinetics of the study drug in pediatric subjects (10 to 12 years old) with bipolar I disorder.


10-12 Year Old With Bipolar I Disorder


Bipolar I Disorder, Pk, Pediatric

For More Information:

Raechel Cooley, B.A

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.